Nerve-sparing retroperitoneal lymphadenectomy

Richard Foster, J. P. Donohue

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Nerve-sparing techniques will undoubtedly occupy a large part of the testis cancer surgeon's armamentarium in the future. More liberal application of such techniques will be seen after chemotherapy as the criteria for patient selection are refined. With better identification of risk factors for relapse, the employment of proactive methods such as nerve-sparing retroperitoneal surgery with or without adjuvant or primary chemotherapy promises to improve patients' options on the basis of solid long-term results, including risk-benefit and cost-benefit analyses.

Original languageEnglish
Pages (from-to)117-125
Number of pages9
JournalUrologic Clinics of North America
Volume20
Issue number1
StatePublished - 1993

Fingerprint

Lymph Node Excision
Cost-Benefit Analysis
Drug Therapy
Testicular Neoplasms
Patient Selection
Recurrence
Surgeons

ASJC Scopus subject areas

  • Urology

Cite this

Nerve-sparing retroperitoneal lymphadenectomy. / Foster, Richard; Donohue, J. P.

In: Urologic Clinics of North America, Vol. 20, No. 1, 1993, p. 117-125.

Research output: Contribution to journalArticle

Foster, Richard ; Donohue, J. P. / Nerve-sparing retroperitoneal lymphadenectomy. In: Urologic Clinics of North America. 1993 ; Vol. 20, No. 1. pp. 117-125.
@article{52c34677b8e5446584334adc66f295de,
title = "Nerve-sparing retroperitoneal lymphadenectomy",
abstract = "Nerve-sparing techniques will undoubtedly occupy a large part of the testis cancer surgeon's armamentarium in the future. More liberal application of such techniques will be seen after chemotherapy as the criteria for patient selection are refined. With better identification of risk factors for relapse, the employment of proactive methods such as nerve-sparing retroperitoneal surgery with or without adjuvant or primary chemotherapy promises to improve patients' options on the basis of solid long-term results, including risk-benefit and cost-benefit analyses.",
author = "Richard Foster and Donohue, {J. P.}",
year = "1993",
language = "English",
volume = "20",
pages = "117--125",
journal = "Urologic Clinics of North America",
issn = "0094-0143",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Nerve-sparing retroperitoneal lymphadenectomy

AU - Foster, Richard

AU - Donohue, J. P.

PY - 1993

Y1 - 1993

N2 - Nerve-sparing techniques will undoubtedly occupy a large part of the testis cancer surgeon's armamentarium in the future. More liberal application of such techniques will be seen after chemotherapy as the criteria for patient selection are refined. With better identification of risk factors for relapse, the employment of proactive methods such as nerve-sparing retroperitoneal surgery with or without adjuvant or primary chemotherapy promises to improve patients' options on the basis of solid long-term results, including risk-benefit and cost-benefit analyses.

AB - Nerve-sparing techniques will undoubtedly occupy a large part of the testis cancer surgeon's armamentarium in the future. More liberal application of such techniques will be seen after chemotherapy as the criteria for patient selection are refined. With better identification of risk factors for relapse, the employment of proactive methods such as nerve-sparing retroperitoneal surgery with or without adjuvant or primary chemotherapy promises to improve patients' options on the basis of solid long-term results, including risk-benefit and cost-benefit analyses.

UR - http://www.scopus.com/inward/record.url?scp=0027497802&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027497802&partnerID=8YFLogxK

M3 - Article

VL - 20

SP - 117

EP - 125

JO - Urologic Clinics of North America

JF - Urologic Clinics of North America

SN - 0094-0143

IS - 1

ER -